These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1815070)

  • 41. Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.
    Ziegler WH; Schalch E; Leishman B; Eckert M
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):63S-69S. PubMed ID: 6138083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary.
    Chen D; Chernik DA; Ellinwood E; Hauri P; Johnson LC; Judd LL; Kripke DF; Linnoila M; Moskowitz H; Roth T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):3S-4S. PubMed ID: 2229461
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics of the newer benzodiazepines.
    Garzone PD; Kroboth PD
    Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans.
    Gudmundsdottir H; Sigurjonsdottir JF; Masson M; Fjalldal O; Stefansson E; Loftsson T
    Pharmazie; 2001 Dec; 56(12):963-6. PubMed ID: 11802661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.
    Schwartz M; Muñana KR; Nettifee-Osborne JA; Messenger KM; Papich MG
    J Vet Pharmacol Ther; 2013 Oct; 36(5):471-7. PubMed ID: 23256899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions.
    Johnson LC; Chernik DA; Hauri P
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):76S-90S. PubMed ID: 2229466
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) people.
    O'Connor-Semmes RL; Kersey K; Williams DH; Lam R; Koch KM
    Clin Pharmacol Ther; 2001 Aug; 70(2):126-31. PubMed ID: 11503006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An experimental study on nasal absorption of gentamycin in dogs.
    Wang JQ; Bu GX
    Chin Med J (Engl); 1994 Mar; 107(3):219-21. PubMed ID: 8088184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
    Fabre LF; McLendon DM; Harris RT
    J Int Med Res; 1976; 4(4):247-54. PubMed ID: 16801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Premedication with midazolam in children. Effect of intranasal, rectal and oral routes on plasma midazolam concentrations.
    Malinovsky JM; Populaire C; Cozian A; Lepage JY; Lejus C; Pinaud M
    Anaesthesia; 1995 Apr; 50(4):351-4. PubMed ID: 7747857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
    Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
    Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of meclizine levels in the plasma of rats and dogs after intranasal, intravenous, and oral administration.
    Chovan JP; Klett RP; Rakieten N
    J Pharm Sci; 1985 Oct; 74(10):1111-3. PubMed ID: 4078711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine.
    Fattinger K; Benowitz NL; Jones RT; Verotta D
    Eur J Clin Pharmacol; 2000 Jul; 56(4):305-10. PubMed ID: 10954344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Rectal, oral and nasal premedication using midazolam in children aged 1-6 years. A comparative clinical study].
    Tolksdorf W; Eick C
    Anaesthesist; 1991 Dec; 40(12):661-7. PubMed ID: 1781563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
    Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
    Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of ranitidine on the disposition of orally and intravenously administered triazolam.
    Vanderveen RP; Jirak JL; Peters GR; Cox SR; Bombardt PA
    Clin Pharm; 1991 Jul; 10(7):539-43. PubMed ID: 1860302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.
    Su KS; Campanale KM; Mendelsohn LG; Kerchner GA; Gries CL
    J Pharm Sci; 1985 Apr; 74(4):394-8. PubMed ID: 3889275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam.
    Bliwise D; Seidel W; Karacan I; Mitler M; Roth T; Zorick F; Dement W
    Sleep; 1983; 6(2):156-63. PubMed ID: 6136085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intranasal and buccal midazolam in the treatment of acute seizures].
    Armijo JA; Herranz JL; Pena Pardo MA; Adín J
    Rev Neurol; 2004 Mar 1-15; 38(5):458-68. PubMed ID: 15029526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.